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Abstract.  The myelin-associated glycoproteins (MAG) 
are members of the immunoglobulin gene superfamily 
that function in the cell interactions of myelinating 
glial cells with axons.  In this paper, we have charac- 
terized the structural  features of these proteins.  The 
disposition of MAG in the bilayer as a type 1 integral 
membrane protein (with an extracellularly disposed 
amino terminus,  single transmembrane  segment, and 
cytoplasmic carboxy terminus) was demonstrated in 
protease protection studies of MAG cotranslationally 
inserted into microsomes in vitro and in im- 
munofluorescent studies with site specific antibodies. 
A  genetically engineered MAG cDNA, which lacks 
the putative membrane spanning  segment,  was con- 
structed and shown to encode a  secreted protein. 
These results confirm the identity of this hydrophobic 
sequence as the transmembrane  segment.  Sequencing 
of the secreted protein demonstrated the presence of a 
cleaved signal sequence and the site of signal pepti- 
dase cleavage. To characterize the disulfide linkage 
pattern of the ectodomain,  we cleaved MAG with cy- 
anogen bromide and used a panel of antibodies to 
coprecipitate specific fragments under nonreducing 
conditions.  These studies provide support for a novel 
disulfide linkage between two of the immunoglobulin 
domains of the extracellular segment.  Finally,  we re- 
port that MAG is posttranslationally palmitylated via 
an intramembranous  thioester linkage.  Based on these 
studies, we propose a model for the conformation of 
MAG, including its RGD sequence, which is consid- 
ered with regard to its function as a cell adhesion 
molecule. 
T 
hE myelin  sheath  is formed by Schwann cells in the 
peripheral  nervous  system and the oligodendrocytes 
in the central nervous system,  as a concentric,  mul- 
tilamellar  spiral around an axon.  Myelin forms in close ap- 
position to, and its formation  is regulated by contact of the 
glial  cell with the surface of the axon  (44).  Cell adhesion 
molecules present on the extending glial process, are thought 
to mediate the interactions  of the glial cell with the axon 
(36).  The  myelin-associated  glycoproteins  (MAGs) 1 are 
considered likely candidates for mediating these interactions 
(31). This suggested role is consistent with their localization 
to the periaxonal membrane (23, 50) and their ability to bind 
to large caliber axons that are destined to become myelinated 
(35). Two isoforms of MAG, designated large MAG (L-MAG) 
and small  MAG  (S-MAG),  have been identified  (19, 37). 
Both are heavily  glycosylated integral  membrane proteins 
(•30%  by weight) that comigrate on SDS-PAGE as a broad 
band of 100 kD. Distinct functions  for each isoform is sug- 
gested by their differential  expression during  development: 
L-MAG is synthesized during the rapid phase of myelination 
1. Abbreviations  used in this paper: IgSF, immunoglobulin family; MAG, 
myelin-associated glycoproteins. 
and  S-MAG is synthesized  predominately in the adult (8, 
19). These isoforms are also differentially phosphorylated in 
vivo (6) and in vitro (1). 
cDNAs for both MAG isoforms  have been isolated and 
characterized  (19, 37).  They are encoded by a single gene 
whose RNA transcript  is alternatively  spliced.  An analysis 
of their deduced amino acid sequences, has suggested poten- 
tial  structure-function  correlates  (37).  Both  proteins  are 
predicted to have an identical,  large extracellular  disposed 
amino-terminai  segment and a single  transmembrane  seg- 
ment (e.g.,  they are type 1 integral  membrane proteins). 
They differ  in  their  carboxy-terminal,  presumptive  cyto- 
plasmic sequences.  The extracellular  segment, which is ex- 
pected to mediate binding  to the axon, contains  five immu- 
noglobulin homology units. The MAG proteins are therefore 
members of the immunoglobulin  gene superfamily  (IgSF) 
(4, 20, 37). They are homologous to a subset of the IgSF that 
includes several well-characterized  cell adhesion molecules, 
including  the neural  cell adhesion  molecule (NCAM), L1, 
and I-CAM 1 (52). Also present in the ectodomain of MAG 
is the tripeptide recognition  sequence Arg-Gly-Asp (RGD). 
RGD sequences are frequently an important determinant of 
the binding  site of cell recognition  and extracellular  matrix 
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receptors, the integrins (11, 33). Determination of whether 
the RGD sequence of MAG is an important functional ele- 
ment therefore, has clear implications as to whether its ax- 
onal receptor is an integrin or whether, like most IgSF mem- 
bers, its axonal receptor is immunoglobulin related. 
While the disposition of MAG within the lipid bilayer has 
been predicted to be conventional, several features of its se- 
quence are atypical for IgSF members.  MAG has  14 cys- 
teines in its ectodomain distributed amongst its five immuno- 
globulin domains.  This suggests that either MAG contains 
free cysteines or that it has more than the single intradomain 
disulfide linkage that is typical of immunoglobulin domains. 
There is an additional cysteine within the predicted mem- 
brane segment, that may also be covalently linked. 
In this paper, we have characterized the structural features 
of MAG. We have confirmed its disposition as a type 1 inte- 
gral membrane protein and identified the site of signal pep- 
tide cleavage. In addition, we have investigated the covalent 
linkages  of the  cysteines present  in  the  ectodomain and 
demonstrated the existence of a novel disulfide linkage be- 
tween immunoglobulin domains of MAG. Finally, we have 
shown that a cysteine within the lipid bilayer is posttransla- 
tionally palmitylated. Based on these studies, we propose a 
model for the conformation of MAG, including the location 
of its RGD sequence. This model is considered with regard 
to the function of MAG as a cell adhesion molecule. 
Materials and Methods 
In Vitro Transcription and Translation 
An L-MAG cDNA was subcloned into the plasmid, pGEM4 (Promega Bio- 
tec, Madison, WI). Complementary RNA was transcribed using SP6 poly- 
merase in the presence of  the RNA cap analogue m7G(5')ppp(5~G  (Pharma- 
cia Fine Chemicals, Piscataway,  NJ)  according to the directions of the 
manufacturer. 1 #1 of  the transcription reaction was used to program a rabbit 
reticulocyte translation system (New England Nuclear, Boston, MA) con- 
taining [3SS]methionine  (New England Nuclear) for 30 rain at 37°C with 
or without canine pancreatic microsomes. For protease protection studies, 
translation rgi~tures were divided into equal aliquots: one was treated on 
ice for 45"~'min with proteinase K(Boehringer-Mannheim Biochemicals) at 
0.5 rng/ml final concentration and the other served as a control. A  10-fold 
excess of ice-cold methanol was then added to precipitate proteins and 
pellets were collected at 13,000 g. Immunoprecipitation procedures are de- 
scribed below. 
Generation of  anti-MAG Antibodies 
Rabbit polyclonals were prepared against two MAG segments: a 20-mer 
corresponding to amino acids  109-128  of the published amino acid se- 
quence of MAG(37), which includes the RGD sequence (peptide 1) and the 
carboxy terminal 20 amino acids of  L-MAG (peptide 2). Both peptides were 
synthesized with carboxy terminal cysteines and were coupled, by cross- 
linking with m-maleimidobenzoyl-N-hydroxysulfosuccinimide  ester (Pierce 
Chemical Co., Rockford, IL) after the manufacturer's instructions, to key- 
hole limpet hemocyanin (KLH). Rabbits were inoculated with the coupled 
peptides as previously described (37). 
Expression of  MAG Isoforms in a Schwann Cell Line 
Construction of a recombinant retrovirus encoding L-MAG has been previ- 
ously described (27). Construction of an S-MAG encoding retrovirus was 
performed in a similar manner. Briefly, Hind HI linkers were added to the 
2087 bp Apa 1 cDNA fragment of S-MAG, corresponding to the complete 
coding sequence and this cDNA was subcloned into the Hind HI site of the 
retroviral  vector,  pMV-7(16).  This  construct  was  introduced  into  the 
ecotropic packaging cell Psi2 by calcium phosphate-mediated DNA trans- 
fection (51). Viral stocks shed by the transfected psi 2 cells were used to 
infect an immortalized Schwann cell line (29) as described (16). Individual 
clones that were resistant to the neomycin analogue, G418 (Gibco Labora- 
tories, Grand Island, NY) at a concentration of 800 #g/ml, were selected 
and checked for their expression of MAG by immunofluorescent staining. 
lndirect Immunofluorescence 
Permanently transfected L-MAG Schwann cells, plated onto glass cover- 
slips, were washed twice with PBS, fixed for 10 min with 4% formaldehyde 
and, in some cases, were then permeabilized with 0.05 % Triton X-100 in 
PBS for 5 min. Cells were washed twice with PBS and then incubated for 
30 rain in PBS/5% normal goat serum to block nonspecific binding. The 
primary antibodies used were the polyclonal antibodies to peptide 1 and 
peptide 2, used at a  1:100 dilution in PBS/5% normal goat serum, and an 
anti-MAG mAb (28), (a gift of Dr. M. Schachner, ETH, Zurich) used as 
undiluted hybridoma culture supernatant. Ceils were incubated for 1 h at 
room temperature then washed, and a secondary antibody, fluoresceinated 
goat anti-rabbit or antimouse (Cappel Laboratories, Malvern,  PA), was 
added at  1:100 in PBS/5%  normal goat serum. Coverslips were washed 
three times in PBS,  mounted in a  PBS-gelatin solution,  and viewed by 
epifluorescence microscopy. 
Construction  of a Recombinant cDNA Corresponding 
to the Ectodomain of  MAG 
To generate a secreted form of  MAG, we introduced a translation stop codon 
amino terminal to the predicted membrane spanning segment of an L-MAG 
cDNA (after nucleotide position 1,665 of the published MAG sequence 
[37]). A sense oligunucleotide and a complementary antisense oligunucleo- 
tide were synthesized (model #380A DNA Synthesizer; Applied Binsys- 
terns, Inc., Foster City, CA), gel purified, and annealed together. The result- 
ing  double  stranded  DNA  fragment  shown  below  contained  an  Xho 
I-compatible overhang 5' on the sense (top) strand, the coding sequences 
of the 15 amino acids proximal to the predicted membrane spanning seg- 
ment, a translation stop codon (TGA), and an Eco RI-compatible overhang 
(3' on the sense strand) to facilitate subcloning into an expression vector. 
5  '-TC  GAG  CTGC  C  TTTC CAGGGAGCACACC  GACTGATG  TGGGC  CAA  ATGAG-  3  ' 
3'-CGACGGAA  AGGTCCC  TCGTGTGG CTGACTACACCC  GGTT  TAC  TCTTAA-5' 
This  double  stranded  fragment  was  then  ligated to  the  1,619-bp  Eco 
RI-Xhol fragment that encodes the major portion of the ectodomain of 
MAG. The resultant cDNA, which encoded the entire extracellular domain 
of MAG, was subcloned into the Eco RI site of the expression vector pMT2 
(15) to create pMT2-ECD. A  similar strategy was also used recently to 
generate a soluble form of MAG in transfected cells (13). 
COS Cell Expression and Purification of  Soluble MAG 
COS-7 ceils were transfected with pMT2-ECD by the DEAE-dextran (22). 
72 h after transfection, culture media was harvested. In most experiments, 
cells were grown under low serum conditions (DMEM with 0.5% Serum 
Plus; Gibco Laboratories), which greatly simplified subsequent purifica- 
tion of the secreted MAG protein because of the reduced level of proteins 
in the media without adversely affecting the level of MAG secretion. The 
media was then concentrated by ultrafiltration over an Amicoti Filter (Ami- 
con Corp., Danvers, MA) (tool mass cutoff  Of 30 kD), and the soluble MAG 
was purified by lentil lectin chromatography, elution with 0.5 M  methyl 
mannoside, followed by fast protein liquid chromatography on a Mono Q 
anion exchange column (Pharmacia Fine Chemicals, Piscataway,  NJ). The 
secreted MAG eluted in phosphate buffered saline using a gradient of NaCI, 
at a concentration of 0.2 M. 
Peptide Sequencing 
Purified soluble MAG was sequenced by automated gas-phase protein se- 
quencing (model 470;  Applied Biosystems, Inc.). 
Immunoprecipitation and Immunobiotting 
Total  cell lysates were prepared by scraping up 106 transfected cells and 
boiling in 2 % SDS. Samples were diluted fourfold with PBS containing 
Triton-X-100 (0.5%) and 1 ml samples were precleared with protein A cou- 
pled to Sepharose CL4B (Sigma Chemical Co.) by incubating with 10 #1 
of beads for 2 h and briefly centrifuging at 13,000 g. The supernatants were 
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mtmoprecipitates were collected with protein A/Sepharose,  released  by 
boiling for 2 min in SDS-PAGE sample buffer, and fractionated by elec- 
trophoresis on 7.5-15% polyacrylamide gradient gel (18). The gels were 
fixed  in  30%  methanol,  10%  acetic  acid,  60%  water,  treated  with 
EN3HANCE  following the manufacturer's instructions (New England Nu- 
clear), and fluorographed.  Western blotting of samples was carded out by 
described procedures (47) and antibodies were visualized with 125I-Protein 
A (ICN Biochemicals,  lrvine, CA). 
Alkylation of Cysteines 
Purified soluble MAG or immunoprecipitated L-MAG (from transfected 
Schwann cells) were alkylated with neutralized 14C iodoacetic  acid (5/~Ci/ 
ml) (ICN Biochemicals) at room temperature in the dark in a  solution 
consisting of 0.2 M Tris-HC1 (pH 8.1), 2 mM EDTA, and 6 M guanidine 
hydroeloride.  Samples  were  either alkylated directly or alkylated after 
prereduction with a  t00-fold molar excess of DTT for l  h at 37°C.  After 
60 min, the alkylation was stopped by quenching with an excess of ~-mer- 
captoethanol. The samples were dialyzed  against 0.1 M Tris,  pH 7.4 and 
analyzed by SDS-PAGE. 
Metabolic Labeling of Cells 
Confluent T-75 flasks of transfected Schwann cells were labeled with either 
[35S]cysteine,  [35S]methionine,  or  [3H]palmitate.  To  label  MAG  with 
[35S]cysteine, cells were preincubated in cysteine-free  DME for 30 rain, 
and then labeled with 100/~Ci/ml of [3~S]eysteine in eysteine-free  DME 
(G-ibco Laboratories) for 2 h at 370C, followed by an additional 2-h chase 
in DME supplemented with 10% FCS.  For the palmitytation studies,  the 
transfected  Schwann  cells  were  labeled  with  400  /~Ci/ml  of  9-10- 
[3H]palmitic  acid (30 mCi/mmol; New  England Nuclear) in DME with 
5 mM Na pyruvate plus 1% FCS for 5 h at 370C. In all cases,  at the end 
of the labeling period the cells were washed twice with PBS, lysed in 2% 
SDS, scraped into a conical tube, sonicated for 60 s and boiled for 2 min 
before immunoprecipitation with anti-MAG antibodies. 
Cyanogen Bromide Cleavage 
5/zl of a cyanogen bromide (CNBr) solution (2 g/ml in DMSO) were added 
to [3sS]Cysteine-labeled  L-MAG immunoprecipitates resuspended in 0.5 
ml of 70%  formic acid.  The reaction mixture was incubated in the dark 
overnight at room temperature. To control for partial cleavage of Asp-Pro 
bonds resulting from incubation in the acidic medium, additional samples 
were incubated in 70% formic acid without CNBr.  The reaction mixture 
was then diluted 10-fold with water and lyophilized.  The lyophilized sam- 
pies were sohibilized in sample buffer (without B-mereaptoethanol),  soni- 
cated for 30 s, and boiled for 2 min. Samples were then immunoprecipitated 
with antiMAG antibodies and analyzed by SDS-PAGE  with or without 
/3-mercaptoethanol  present. 
Characterization of the Palmitoyl Moiety 
To analyze the sensitivity of the MAG-palmityl  bond to neutral hydroxyl- 
amine, MAG labeled with [3H]palmitate was separated  by SDS-PAGE and 
the gels were soaked for 4 h at room temperature in at least 10 vol of 1 M 
Tris (pH 7.0) or 1 M hydroxylamine  (pH 7.0). The gels were then washed 
for 1 h in water and prepared for fluorography. Quantitation of fluorographs 
was performed by optical densitometry. 
To identify the nature of the acyl group,  the immunoprecipitates of the 
MAG labeled with [3H]palmitic acid were washed in deionized water and 
then in methanol. The immunoprecipitates were incubated for 4 h in 1 ml 
0.l M KOH in methanol. The supernatant yeas removed and extracted with 
2 vol of chloroform/water (1:1); the upper (aqueous)  phase was reextracted 
with 1 vol of chloroform. The organic phases were combined and washed 
three times with chloroform/methanol/water (1:10:10). The final organic 
phase was dried under a nitrogen stream, redisselved in methanol, and ana- 
lysed by reverse-phase HPLC on a CI 8 column (Supelcosil LC-318, 4.6 mm 
×  25 cm). The mobile phase was acetonitrile/water (85:15, vol/vol);  with 
a flow rate~f I ml/min. Standards consisting  of myristic acid, palmitic acid, 
methyl myristate, and methyl palmitate (Sigma  Chemical Co.) were  in- 
jected with the radioactive sample.  Fractions were collected at I min inter- 
vals while monitoring at 210 nm by UV absorption, and radioactivity in in- 
dividual fractions was determined by scintillation counting. Data analysis 
and graphics were done on a Macintosh II computer. 
Figure  1.  Characterization of antipeptide  antibodies.  MAG pro- 
teins,  expressed  by  transfected  cells,  were  fractionated by  SDS 
PAGE and blotted as described  (47).  Samples  include a  recom- 
binant soluble form of the ectodomain of MAG (rs MAG) secreted 
by transfected COS cells (lane a), and total cell lysates of S-MAG 
(lane b) and L-MAG (lane c) transfected Schwann cells. Primary 
antibodies were used at a  1:1,000 dilution and consisted of the an- 
tipeptide 1 antibody directed against the RGD and surrounding se- 
quences (A) and the antipeptide 2 antibody specific to the carboxy 
terminus  of  L-MAG  (B).  The  blots  were  incubated  with  125I- 
protein A  and exposed for autoradiography. 
Results 
Characterization of the Antipeptide Antibodies 
Site-specific antibodies were generated to the RGD sequence 
of MAG (peptide  1) and to the carboxy-terminal 20 amino 
acids of L-MAG  (peptide 2).  The specificity of each anti- 
body was confirmed by Western blotting. Samples of culture 
supernatant  containing the soluble extracellular domain of 
MAG (rsMAG) (lane a), or cell lysates of transfected  S-MAG 
(lane b), and L-MAG (lane c) cells were fractionated by SDS 
PAGE and blotted  (Fig.  1).  Primary  antibodies  used were 
directed against antipeptide  1 in Fig.  1 A and antipeptide  2 
in Fig. 1 B. The antipeptide 1 antibody (which recognizes the 
RGD segment of MAG) reacted with all three forms of MAG 
whereas the antipeptide  2 antibody  (which recognizes the 
carboxy terminus of L-MAG) only reacted with L-MAG. 
These results  confirm the specificity  of these antibodies. 
Their use inthe analysis of the disposition of MAG and the 
arrangement  of the disulfide linkages of MAG is described 
below. It should be noted that the relative molecular mass of 
both isoforms of MAG expressed by fibroblasts  (Fig.  1) and 
Schwann cells (Fig.  6  and 7) is somewhat larger  than that 
present in myelin (L-MAG has a M, of 120 kD and S-MAG 
has a Mr of 115 kD), reflecting the more extensive glycosy- 
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mRNA for L-MAG  was translated in a reticulocyte  ly- 
sate system in the presence of increasing amounts of 
dog pancreas microsomal membranes (rob). The pri- 
mary translation product, is indicated  by the lower ar- 
row (A), and the core glycosylated  polypeptide, syn- 
thesized in the presence of microsomal membranes 
(lanes c, e, and g), is indicated by the upper arrow. 
Samples treated with endoglycosidase  H are shown  in 
lanes d, f, and h. (B) Protease K treatment of MAG 
co-translationally inserted into  microsomes. MAG 
peptides were immunoprecipitated with an antibody 
directed against the RGD segment after in vitro trans- 
lation without (lanes a and b) or with (lanes c and d) 
microsomal membranes. Samples treated with pro- 
teinase K are in lanes b and d. The cotranslationally 
inserted polypeptide that remains after proteinase K 
treatment is indicated (arrow, lane d). 
lation of MAG previously observed (12) in some transfected 
cells. 
Disposition of  MAG in the Membrane 
Previous analysis (37) of its amino acid sequence, suggested 
that  MAG,  like  most  immunoglobulin gene  superfamily 
members, is a typical type I (34) integral membrane protein, 
e.g., it has an extraceUularly disposed amino terminus, a sin- 
gle membrane spanning segment, and a cytoplasmic carboxy 
terminus. We have confirmed this disposition using an in 
vitro transcription-translation system to direct the synthesis 
and cotranslational insertion of L-MAG into microsomes 
and then analyzed its disposition within the microsome in 
protease  protection  studies.  An  mRNA  for  L-MAG was 
translated in a  reticulocyte lysate with or without purified 
dog pancreas microsomes. When synthesized in the presence 
of microsomai membranes,  the  translated  L-MAG  shifts 
from an Mr of 69 to an Mr of 94 kD (Fig. 2 A), correspond- 
ing to the core glycosylated polypeptide. This glycosylated 
polypeptide is cleaved to an Mr of 70 kD by endoglycosi- 
dase H. Although predicted to have a cleaved signal sequence, 
the molecular weight of the processed protein after endo H 
treatment was not decreased compared to that of the primary 
translation product.  This is likely to reflect N-acetyl glu- 
cosamine residues that remain after enzymatic deglycosy- 
lation. 
To determine the orientation of the cotranslationaily in- 
serted polypeptide within the microsome membrane, the to- 
tal translation mixture was treated with proteinase K. After 
protease digestion, a fragment of Mr of 85 kD remains (Fig. 
2 B, arrow). This protected fragment corresponds to the 
intraluminal segment (the future ectodomain) and the mem- 
brane-spanning segment. This fragment was specifically im- 
munoprecipitated  by  the  antipeptide  1  antibody directed 
against the RGD and surrounding sequences but not by the 
antipeptide 2 antibody directed against the carboxy terminus 
of L-MAG (data not shown). These results indicate that the 
major portion of the amino terminus of MAG is extracellu- 
larly disposed (e.g.,  intraluminal), that MAG crosses the 
membrane only once (since only one fragment results from 
the protease treatment), and that there is a short (10 kD) 
carboxy-terminal segment that is cytoplasmic (extraluminai 
and therefore degraded by proteinase K). 
This  disposition  was  confirmed by  immunofluorescent 
studies of  the transfected cells expressing L-MAG or S-MAG 
with the antipeptide antibodies (Fig. 3). The surface expres- 
sion of L-MAG is apparent in both nonpermeabilized (a) and 
permeabilized cells (b) when stained with MA513, an mAb 
that recognizes the native conformation of MAG(28).  Sur- 
prisingly, essentially no staining was visible with the an- 
tipeptide 1 antibodies that recognize the RGD sequence of 
MAG either before (Fig. 3 c) or after (Fig. 3 d) permeabili- 
zation with 0.05 % Triton X-100. These results suggest that 
this region of MAG is conformationally inaccessible unless 
MAG is first denatured, and are consistent with other studies 
described below.  By contrast,  excellent staining was seen 
with  the  antibody  specific  for  the  carboxy  terminus  of 
L-MAG, but only after cells were permeabilized, consistent 
with the intracellular localization of this epitope (compare 
Fig. 3, e and  f). The specificity of the antipeptide 2 antibody 
in  immunofluorescence was  confirmed using S-MAG ex- 
pressing cells; no staining of these cells was apparent before 
or after permeabilization (Fig. 3, g and h). 
MAG Has a Cleaved Signal Sequence and a Single 
Transmembrane Segment 
The myelin associated glycoproteins have two extended hy- 
drophobic segments. The first consists of '~ 20 amino acids 
at the amino terminus that is predicted to be a cleaved signal 
sequence (10). The second, consisting of 23 nonpolar amino 
acids (514-536  of the published MAG sequence  [37]),  is 
likely to be the single membrane spanning segment of MAG 
demonstrated in the in vitro translation studies described 
above. To confirm the function of  these two hydrophobic seg- 
ments directly, we inserted a translation termination codon 
in the cDNA of L-MAG immediately 5' to the predicted 
membrane-spanning segment (after amino acid 513),  and 
subcloned this recombinant cDNA  construct into the eu- 
The Journal of Cell Biology, Volume 111,  1990  2654 Figure 3. Aecessibility  of MAG epitopes: reactivity with a MAG monoclonal and anti-peptide antibodies. Immunofluorescent staining of 
cells expressing L-MAG (a-f) or S-MAG (g and h) is demonstrated. Cells on the right side of the figure (b, d,f, and h) were permeabilized 
with 0.05%  Triton before incubation with antibodies. Antibodies used included a MAG monoclonal (MA513) that recognizes the native 
conformation of MAG(28) (a and b), and antibodies against the RGD (c and d) or carboxy-terminal segments (e-h) of L-MAG. 
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the e~etodomain  of  MAG. A recombinant 
protein (rsMAG) corresponding to the 
ectodomain of MAG, was treated with 
the  alkylating  reagent,  ~4C-iodoaeeta- 
mide, and the resultant material was sep- 
arated by SDS PAGE. In lane a, rsMAG 
was treated directly with iodoacetamide. 
In lane b, rsMAG was first reduced with 
ITI'T before treatment with  iodoaceta- 
mide. Minor contaminants in the rsMAG 
preparation (lane b) are faintly visible at 
160 and 25 kD. 
karyotic expression vector, pMT2 (15).  This construct was 
then used to transiently transfect COS cells. In contrast to 
the full length L-MAG protein, which is targeted appropri- 
ately to the plasma membrane, the truncated protein, which 
lacks the second hydrophobic segment, is no longer retained 
at the cell surface but is  instead secreted into the culture 
media  (Fig.  1).  This  recombinant,  soluble  MAG  protein 
(rsMAG),  migrates  on  SDS-PAGE  with  a  Mr  of 85  kD, 
compared to native MAG present in myelin that migrates as 
a broad band of 100 kD. The shift in molecular mass of,~15 
kD is consistent with the deletion, in rsMAG, of the mem- 
brane  and  cytoplasmic segments.  After enzymatic degly- 
cosylation, the Mr shifts to 57 kD, reflecting removal of the 
extensive N-linked carbohydrate chains (data not shown). 
Next, we confirmed the role of the amino-terminal hydro- 
phobic segment as a cleaved signal segment by direct amino 
acid sequencing of rsMAG.  Although predicted to have a 
cleaved signal peptide, the site of signal peptidase cleavage 
was unknown, as MAG purified by published methods (32) 
has been reported to have a blocked amino terminus.  We 
purified the secreted MAG protein by a combination of ul- 
trafiltration,  lentil  lectin chromatography,  and  FPLC,  to 
obtain a preparation of rsMAG that was >90% pure by SDS- 
PAGE. We determined the amino terminal sequence by sub- 
jecting this material to 15 cycles of Edman degradation. The 
directly determined amino acid sequence begins with gly- 
his-trp-gly-etc, and corresponds to a sequence beginning at 
amino acid 20 of the published MAG sequence 07). These 
results confirm our previous prediction that MAG is cleaved 
during  its  cotranslational  insertion  into  the  microsomal 
membrane and that the site of cleavage is after amino acid 
19 of the propeptide (37). 
The results of these studies indicate that the two isoforms 
of MAG correspond to polypeptides of 607 amino acids for 
L-MAG and 563 amino acids for S-MAG with molecular 
masses of 67.1 and 62.1 kD, respectively. Both proteins have 
identical ectodomains of 494 amino acids and membrane- 
spanning segments of 23 amino acids, but differ in the extent 
and  sequences  of their  cytoplasmic  segments  (90  amino 
acids for L-MAG and 46 amino acids for S-MAG). 
A  Novel Disulfule Linkage Present in the Ectodomain 
To further characterize the structure of MAG, we have deter- 
mined its pattern of disulfide bonds.  Immunoglobulin do- 
mains typically contain a single intradomain disulfide link- 
age whose function may be to stabilize the conformation of 
the Ig fold and confer stability against extracellular proteases 
(52). The ectodomain of MAG has five immunoglobulin do- 
mains, containing a total of 14 cysteines. The distribution of 
these cysteines consists of three in each of the first two Ig do- 
mains, two each in the third and fourth domains (the most 
conventional Ig-like domains of MAG), and four in the fifth 
(membrane proximal) domain (see Fig. 5). 
We first determ'med whether any of the cysteines of  the ec- 
todomain of MAG are unconjugated,  or whether they all 
form disulfide bonds.  ~4C-labeled iodoacetamide, an alkyl- 
ating reagent, was used to label free sulfhydryl groups. None 
of the cysteines of rsMAG  (Fig.  4)  or L-MAG (data not 
shown) were labeled by this reagent, unless they were first 
reduced with DTT.  These results suggest that all of the cys- 
teines in the ectodomain are disulfide linked, a finding that 
is further supported by a comparison of the electrophoretic 
mobility of L-MAG and rsMAG under reducing and non- 
reducing conditions. Both L-MAG and rsMAG migrate more 
rapidly under nonreducing conditions than under reducing 
conditions; for example L-MAG migrates witth an Mr '~90 
vs. 'o120 kD, respectively (lanes a, Fig. 6 A vs. Fig. 6 B). 
This migration pattern is consistent with the presence of ex- 
tensive disulfide linkages in the ectedomain that stabilize a 
compact  structure  during  SDS-PAGE  under  nonreducing 
conditions. 
Next, we determined how the additional cysteines present 
in the first, second, and fifth domains are conjugated. One 
possibility was that MAG might be covalently linked to itself 
to form a homodimer, or to another protein to form a heter- 
omer, similar to the covalently linked heterodimers formed 
by immunoglobulin heavy and light chains. The migration of 
MAG as a monomer under nonreducing conditions on SDS 
PAGE (Fig. 6 A, lane a) excludes these possibilities, how- 
ever. Therefore, the disulfide linkages of MAC; must all be 
intrachain. Two other models were thus considered likely: 
either that the additional cysteines present in domains one 
and two are linked to each other Oinking domains one and 
two), or alternatively that these cysteines are disulfide linked 
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Figure 5. Cyanogen bromide cleavage pattern of MAG. In this dia- 
gram,  the  five Ig  domains  of MAG are  shown as boxes. The 
predicted sites of CNBr cleavage (corresponding to the location of 
the methionine residues) are indicated by breaks in the diagram- 
matic model of  MAG. The location of  the 15 cysteines (C) are num- 
bered sequentially. The size in kilodaltons of the CNBr fragments 
predicted for complete cleavage, including 4 kD for each potential 
N-linked glycosylation site, is given at the bottom. The location of 
the RGD peptide (against which an antibody was raised) is shown 
at the end of domain one. Modified from reference 37. 
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are disulfide linked. [35S]Cysteine-labeled  MAG from 
transfected  Schwarm  cells was immunoprecipitated  and 
cleaved with cyanogen  bromide. This material was run 
on SDS-PAGE under non-reducing conditions (A) or 
reducing conditions (B). In A, the uncleaved  initial im- 
mtmoprecipitate  of MAG is shown in lane a and the to- 
tal material after cyanogen  bromide cleavage  in lane b. 
Fragments were specifically immunoprecipitated with 
antibodies to the RGD sequence of domain one (lane 
c), the antiMAG monoclonal GEN $3 (lane d), or an 
antibody to the carboxy-terminal 20 amino acids of 
L-MAG (lane e). In B, the uncleaved immunoprecipi- 
tare of MAG is shown in lane a and the total material 
after cyanogen  bromide cleavage  in lane b. Fragments 
that precipitated with the  antiRGD antibody before 
reduction (lane c) or after reduction (lane d) or with 
GEN $3 before (lane e) or after (lane  f) reduction are 
shown. The arrowhead indicates the  14-kD doublet 
precipitated by the antibody specific for the carboxy 
terminus of  L-MAG (lane  g). Molecular weights shown 
are estimated from the position of standards. 
to two of the four cysteines present in domain five (thereby 
linking domains one, twos, and five). 
To distinguish  these possibilities,  we first cleaved [35S]- 
cysteine-labeled L-MAG with cyanogen bromide (CNBr) to 
generate specific fragments of MAG.  (The position of the 
methionines in the L-MAG molecules, and the size of  the ex- 
pected fragments after CNBr cleavage are shown in Fig. 5). 
We then determined which domains remain covalently  linked 
after immunoprecipitation under non-reducing conditions. 
We found that after cyanogen bromide treatment, antibodies 
against peptide 1 (the RGD sequence of domain 1) immuno- 
precipitate a fragment of Mr ,,o35 kD (Fig. 6 A, lane c). Af- 
ter reduction, this fragment resolves into two fragments of 
Mr 20 and 14 kD (Fig. 6 B, lane c). The larger 20-kD frag- 
ment was demonstrated to correspond to domain one as it 
is the only fragment immunoprecipitated by the anti-RGD 
antibody under reducing conditions (Fig. 6 B, lane d). The 
14-kD fragment with which it coprecipitates corresponds to 
the size expected for the fragment of domain two resulting 
from CNBr cleavage. In addition, the intensity of labeling of 
these two fragments is proportionate to their expected con- 
tent of cysteines (four in the 20-kD fragment and two in the 
14-kD fragment; see Fig.  4).  Domain five (which is con- 
tained within a larger fragment of 40 kD that also includes 
domain four), does not coprecipitate with domain one and 
two under nonreducing conditions.  These results  indicate 
that only domain one and two are disulfide linked and that 
domain five, which contains four cysteines, must have two 
intradomain disulfide linkages. 
To demonstrate the specificity of the immunoprecipitation 
of domain one with the antiRGD antibody, parallel studies 
were performed with two other antibodies.  A  monoclonal 
anti-MAG antibody, GEN $3 (25), whose epitope was previ- 
ously unknown, specifically immunoprecipitates the domain 
two fragment (Fig. 6 B, lane f) under reducing conditions. 
Like the antiRGD antibody, under nonreducing conditions 
the monoclonal antibody recognizes a fragment of Mr =  35 
kD (Fig. 6 A, lane d), which resolves into the 20- (domain 
one) and 14-kD (domain two) fragments when analyzed by 
reducing SDS PAGE (Fig. 6 B, lane e), confirming the link- 
age of domain one with two. By contrast, the antipeptide 2 
antibody specific for the carboxy terminus of L-MAG, im- 
munoprecipitates a predicted fragment of 14 kD as well as 
a larger, partially cleaved fragment of MAG (Fig. 6 A, lane 
e and Fig. 6 B, lane g). The electrophoretic mobility of the 
14-kD carboxy-terminal fragment is identical under reduc- 
ing and nonreducing conditions, consistent with the absence 
of a disulfide linkage in this segment. This carboxy-terminal 
fragment typically runs as a doublet, possibly reflecting het- 
erogeneity in the extent of its phosphorylation (1) or paimity- 
lation (see below). 
MAG Is PosttranslationaUy Palmitylated via a 
Thioester Linkage 
There is an additional cysteine in the membrane spanning 
segment of MAG. When L-MAG was treated with [14C]io- 
doacetamide, this cysteine remained unlabeled suggesting it 
also participates in a covalent linkage (data not shown). As 
cysteines present within or near the cytoplasmic side of the 
bilayer  in  other  integral  membrane  proteins  have  been 
demonstrated to be posttranslationally palmitylated via  a 
thioester linkage (48), we examined whether MAG might be 
similarly palmitylated. 
Transfected Schwann cells expressing MAG, were pulse- 
labeled  with  either  [35S]methionine  or  [3H]palmitate and 
the label associated with MAG was characterized.  Under 
conditions of continuous labeling with [35S]methionine, two 
forms of L-MAG are detected (Fig. 7 A, lane a). These cor- 
respond to Mr's  of 94  and  120 kD.  The lower molecular 
weight form corresponds to the core glycosylated, ER form 
of MAG as evidenced by pulse-chase studies in which this 
form appears first in short labeling periods (15 min). After 
a 60-min chase, the mature form (the upper band) first ap- 
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immunoprecipitated  from  transfected  Schwann cells  expressing 
L-MAG that were continuously labeled for 5 h with [35S]methionine 
(lane a) or [3I-I]palmitate (lane b), and then fractionated by SDS- 
PAGE (7.5-15% acrylamide gradient). Two forms of MAG are evi- 
dent in lane a, the core glycosylated form (MAGo) and the mature, 
fully glycosylated form (MAGi). [3H]Palmitate is specifically only 
incorporated into the mature form of MAG (lane b). (B) Treatment 
with  hydroxylamine releases  3H-palmitate. Transfected Schwann 
cells were pulse labeled with [35S]methionine for 2 h followed by a 
chase for an additional 2 h (lanes a  and c) or with [3H]palmitate 
continuously for 5 h (lanes b and d). The majority of the MAG evi- 
dent in lanes a and c, is the mature, fully glycosylated form of  MAG. 
After electrophoresis, the gel was divided in two and incubated for 
1 h at room temperature in  1 M Tris, pH 7.0 (lanes a  and b) or 
1 M hydroxylamine, pH 7.0 (lanes c and d). After rinsing with water, 
the gels were processed for fluorography. 
pears and after a 2-h chase, most of the labeled MAG present 
is the mature form (compare lanes a of Fig. 7, A and B). The 
higher molecular weight form of MAG is the only form pres- 
ent at the  cell  surface,  based on external labeling  (21)  of 
Schwann cells (data not shown). When cells were labeled in 
parallel  with  pH]palmitic acid,  only the  mature,  120-kD 
form of MAG was labeled, while the core glycosylated, ER 
form of the protein was not (Fig.  7 A, lane b).  In parallel 
studies, labeling by PH]palmitic acid of S-MAG was simi- 
larly restricted to just the mature form (data not shown). 
These  results  indicate  that  MAG  is  posttranslationally 
acylated. Further, these results suggest that minimal conver- 
sion  of the  pH]palmitic acid  to  an  amino  acid  occurred 
during the period of labeling as the newly synthesized MAG 
(MAGo)  was unlabeled. 
To clarify the nature of the fatty acylation, and to exclude 
the  possibility  that  the  palmitate  had  been  converted  to 
myristate, we characterized the fatty acyl group and its cova- 
lent linkage.  Palmitylation typically occurs via an alkaline 
labile thioester linkage, whereas myristylation typically oc- 
curs via a  hydroxylamine stable amide linkage (48).  First, 
we incubated the gel displayed in Fig. 7 B in hydroxylamine 
for 4 h at room temperature under conditions expected to hy- 
drolyze thioester but not amide linkages. Under these condi- 
tions, up to 80% of the [3H]palmitic acid label in MAG was 
removed, while the 3~S-methionlne  label in MAG was un- 
affected. This result indicates that the incorporated label rep- 
resents lipid bound to this protein through a thioester link- 
age. The [3H]palmitate-labeled MAG was also treated with 
KOH and methanol to release the acyl group. The fatty acid 
that was released by this treatment was then characterized by 
HPLC. As shown in Fig.  8, the 3H label migrates with the 
same mobility as methyl-palmitate and palmitate, consistent 
with its identification as a palmitoyl group. 
Discussion 
Although the role of MAG in myelination has not been estab- 
lished, evidence to date suggests that it mediates a complex 
set of interactions,  that include binding to a  receptor on a 
subset of axons  (12,  27),  binding  to  extracellular  matrix 
components (7) and, possibly, promoting adhesion between 
the apposed membranes of the myelinating Schwann cell at 
specific sites (38, 49). These complex interactions in turn im- 
ply the existence of multiple functional sites that are perhaps 
reflected in  the  extraordinary degree of conservation dis- 
played by all segments of MAG during evolution. Thus hu- 
man (39,  43) and mouse (9) MAG show an overall 95 and 
98 % identity of amino acids respectively with rat MAG. The 
RGD sequence and the number and location of the cysteines 
have been conserved. As nothing was known about the con- 
formation of MAG or its disposition within the membrane, 
we undertook the studies described in this paper to clarify 
the  structure of these proteins as a  prelude to identifying 
their discrete functional elements. These studies confirm the 
disposition of MAG within the bilayer as a type one integral 
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Figure  8.  Characterization  of  the  acyl  group  of  MAG.  Im- 
munoprecipitates  of MAG  labeled  with  [3H]palmitate were  in- 
cubated for four hours in 0.1  M KOH in methanol. The released 
material  was  subjected to  HPLC  as  described  in  Materials  and 
Methods. Two peaks of radioactivity are evident. Fractions contain- 
ing the standards myristic acid, palmitic acid, methyl myristate, and 
methyl palmitate are indicated. 
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Figure 9. Model for the conformation of MAG. Diagram showing the major structural features of MAG discussed in this paper. Shown 
are the five immunoglobulin domains of the extracellular segment, with the first domain folded as a variable domain and all other domains 
folded as constant (C2) domains. The predicted position of the cysteines and their disulfide linkages axe also indicated including an interdo- 
main disulfide linkage of C1 and C5, and the intrasheet disulfide linkages of C2 and C3, and Cll and C12. The palmitoyl group present 
on the intramembranous cysteines is indicated (o) and the predicted position of the RGD sequence (*) of MAG within the first domain 
is shown. 
membrane protein, suggest a unique arrangement of its im- 
munoglobulin domains,  and demonstrate the post-transla- 
tional palmitylation of its intramembranous cysteine. 
MAG is a member of the C2 set of the immunoglobulin 
gene superfamily (53) and contains five Ig domains in its ex- 
tra~ellular segment (19, 37). (C2 domains have features in- 
termediate between variable [V] and constant [C] Ig domains 
in containing the cysteine spacing and seven/~ strands typical 
of C domains but sequences which are more homologous to 
V  domains  [53]).  They are characteristic of multidomain 
IgSF members that mediate cell adhesion (36, 52). Domains 
three and  four are the most conventional C2  domains  of 
MAG. These domains show the highest degree of homology 
to other members of this subset of proteins, which includes 
NCAM and L1 in the nervous system, and I-CAM 1 in ex- 
traneural sites. Domains three and four each contain two cys- 
teines  that  are  presumed  to  form  a  typical  intradomain 
disulfide linkage. 
The other domains of MAG containmore than the two cys- 
teines necessary to form an intradomain disulfide linkage. 
Domains one and two contain three cysteines each, whereas 
domain five contains four cysteines. As there are no free cys- 
teines in the ectodomain of  MAG (Fig. 4), the additional cys- 
teines  of domains  one  and  two  must  either be  disulfide 
bonded to each other (linking domains one and two) or to 
the extra cysteines of domain five (linking domains one, two, 
and five). A  priori,  the former possibility appeared more 
likely as a disulfide linkage of domains one and two with the 
clustered cysteines of domain five (three of which occur in 
a stretch of 12 amino acids), would seem to be precluded on 
steric grounds. Evidence presented here confirms this expec- 
tation, indicating that only domains one and two are disulfide 
linked to each other. Thus, these two domains were found 
to coprecipitate with each other stoichiometrically, but not 
with domain five, under nonreducing conditions (Fig. 6). 
Several features of tim t~rimary sequence of the ectodo- 
main are relevant to further predictions of the conformation 
of MAG. Because of the location of the cyanogen bromide 
cleavage site (shown in Fig. 5), the coprecipitation of the do- 
main two fragment with domain one indicates that either cys- 
teine five or six of thi  s fragment must be disulfide linked to 
one of the first four cysteines of MAG. In view of the homol- 
ogy of their surrounding sequences to those present in other 
Ig domains, cysteines four and six would be expected to form 
the intradomain disulfid  e linkage of domain two, suggesting 
that cysteine five is covalently linked to a  cysteine of the 
first domain. A. Williams and his colleagues have recently 
pointed out that the first domain of MAG has atypical fea- 
tures for a C2 domain (53). In particular, domain one shows 
the greatest homology to other IgSF proteins when  it' is 
folded as a V domain, with 9 beta strands, a model that also 
optimizes the conserved beta strand assignments for this do- 
main (53). If the first domain of MAG is folded as a V do- 
main,  several additional consequences result.  The second 
and third cysteines would be in predicted t3 strands b and e 
respectively of the immunoglobulin fold, and in a position 
to form an unusual  intrasheet disulfide linkage with each 
other. This arrangement also places the first cysteine of do- 
main one in a position to form a disulfide linkage with cys- 
teine five of domain two. 
The RGD sequence was originally proposed to be in the 
hinge region between domains one and two (37) and a poten- 
tially  important  functional  determinant.  However in  the 
model  discussed  above,  the  RGD  segment  (shown as  an 
asterisk in Fig. 9) now falls into the interior of the first do- 
main,  in/3 strand f. In this position, the accessibility and 
functional importance of  the RGD sequence as a ligand bind- 
ing site would likely be limited. A location buried within the 
first domain is consistent with the inability of the anti-RGD 
antibody used in these studies to recognize MAG in its native 
conformation (Fig. 3, c and d), although it reacts well with 
SDS  denatured MAG  (Fig.  1 A).  Also  consistent with  a 
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in which synthetic peptides containing the RGD sequence 
failed to block the adhesion of MAG, incorporated into lipo- 
somes, to axons (35).  These more recent studies and this 
model of the conformation of MAG suggest that the axonal 
receptor MAG is more likely to be another member of the 
IgSF rather than an integrin. 
The fifth domain of MAG is also atypical for C2 domains 
in containing four cysteines. As none of these cysteines are 
free, domain five must contain two disulfide linkages. C13 
and C14 can be aligned to form a conventional intradomain 
disulfide linkage (between/3 strands b and f). The two addi- 
tional cysteines, Cll and C12, are then predicted to be in 13 
strands a and b, respectively, and in a position to form a sec- 
ond intrasheet disulfide linkage. Based on these arguments, 
we present a schematic model of MAG in Fig. 9 showing its 
orientation within the bilayer, its presumptive disulfide link- 
ages, and the palmitoyl group on the intramembranous cys- 
teine. 
MAG is not the only  IgSF member with additional cysteines 
present in the ectodomain. Of  particular interest  are the lym- 
phoid differentiation antigen CD33(42) and the B cell adhe- 
sion molecule CD22 (45): integral membrane proteins with 
two and five extracellular immunoglobulin domains, respec- 
tively.  Both proteins share an ,,025%  amino acid identity 
with the first two domains of MAG. They each contain six 
cysteines in their amino-terminal two domains which are 
present in equivalent positions to their counterparts in MAG. 
These presumably form an interdomain disulfide linkage 
similar to that shown here for MAG. These findings further 
suggest that these two domains of MAG may represent a dis- 
crete functional element that may be evolutionarily related 
to these proteins. 
Other IgSF members with an excess of cysteines per do- 
main include c-Kit (30), ICAM 1 (46), and the poly Ig recep- 
tor (24).  Whether these molecules will contain interdomain 
disulfide linkages remains to be determined, but the findings 
here suggest that an interdomain disulfide linkage may be 
fairly common among IgSF members and of  potential impor- 
tance in  stabilizing these proteins  in  an optimal confor- 
mation. 
One additional feature of  the MAG proteins shown in these 
studies is the presence of a palmitoyl group on the cysteine 
within the membrane (seven amino acids in from the cyto- 
plasm). Although more commonly located in the cytoplasm 
and near the bilayer, an intramembranous palmitylated cys- 
teine has previously been reported for the class II MHC anti- 
gen (14). Like many other proteins, MAG is palmitylated 
only on the mature form of the protein, i.e., the palmitoyl 
moiety is added posttranslationally, possibly in a transition 
element of the ER or in the cis-Golgi (40, 41).  The linkage 
of the palmitic acid moiety to the majority of the acyl pro- 
teins described to date has been identified as an oxyester or 
thioester bond. In the case of MAG, we have shown that the 
palmitic acid moiety is bound to the polypeptide through a 
thioester bond based on its sensitivity to alkaline methanol- 
ysis and hydroxylamine. 
It is intriguing to note that fatty acylation of myelin pro- 
teins is a common theme. The major structural proteins of 
myelin, proteolipid protein in the central nervous system (5), 
and the P0 protein in the peripheral nervous system (2), are 
both  palmitylated.  The  myelin protein  cyclic  nucleotide 
phosphodiesterase has also recently been demonstrated to be 
palmitylated (3).  Evidence has been presented for the pres- 
ence of a  fatty acyl transferase activity within the myelin 
sheath (5), suggesting that all of these myelin specific pro- 
teins may be acylated by a common mechanism. 
As is true with other proteins, the functional significance 
of this palmitylation is not known. In the case of the struc- 
tural proteins of  myelin, Po and PLP, this fatty acylation may 
reflect their location and need to function within the highly 
hydrophobic environment of the compact myelin sheath. By 
contrast, MAG is present only in the noncompacted mem- 
branes of myelinating cells (50),  suggesting that its palmity- 
lation serves a different role. One function of the fatty acyla- 
tion of other integral membrane proteins, is to regulate the 
assembly of  protein multimers. Thus, in the case of  the major 
histocompatibility antigen, Ia, palmitylation may prevent di- 
merization, by inhibiting the formation of  disulfide bonds be- 
tween two adjacent molecules (17). The inhibition of fatty 
acylation and dimerization in turn blocks post-translational 
maturation, in particular~ the addition of sialic acid: There 
is also evidence their fatty acylation may be important for the 
assembly of the a  cetylcholine receptor complex and its sur- 
face expression (26). Whether palmitylation  may also modu- 
late the intramembranous associations and lateral mobility 
of MAG or, alternatively whether it may regulate the binding 
activity of the ectodomain or of the cytoplasmic domains of 
MAG, is as yet unknown. 
In sum, we have shown that MAG is a type one integral 
membrane protein ~;vith  an unusual arrangement of its immu- 
noglobulin doniains, a sterically inaccessible RGD sequence, 
and a  post-translational palmitylation of its intramembra- 
nous cysteine. The availability of  eDNA clones for MAG that 
can be modified  and expressed in ~i myelinating  tissue culture 
system (27), should facilitate our understanding of the func- 
tional significance of these structural features of MAG. 
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